Overview

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Status:
Terminated

Trial end date:
2018-03-30

Target enrollment:

Participant gender:

Summary

This study will assess the safety and efficacy of the brimonidine intravitreal implant in participants with geographic atrophy due to age-related macular degeneration.

Phase:

Phase 2

Details

Lead Sponsor:

Allergan

Treatments:

Brimonidine Tartrate